The duration of dual antiplatelet therapy (DAPT) should be individualized based on ischaemic and bleeding risk of a particular patient, rather than focusing on a dualistic short- vs long-duration therapy thinking, advocates a leading expert during AFCC 2018.
The burden of heart failure (HF) in Asia is high compared with the US and Europe, with Southeast Asia (SEA) having the highest HF prevalence vs other Asian regions combined, and the youngest patients having the worst outcomes, according to data presented at AFCC 2018.
Mitral valve (MV) repair appears to be associated with a lower mortality rate and better clinical outcomes in patients with infective endocarditis compared with MV replacement, according to review of previous studies presented at AFCC 2018.
Treatment with the nonselective aldosterone receptor agonist spironolactone can significantly reduce ventricular arrhythmic events in patients with implantable cardioverter defibrillator (ICD), according to a Thailand study presented at the 23rd ASEAN Federation of Cardiology Congress (AFCC 2018).
The lower threshold for hypertension diagnosis in the 2017 ACC/AHA hypertension guidelines does not necessarily entail more pharmacological treatment, says a leading expert in cardiology during a presentation at AFCC 2018, who highlights that the first key step for managing hypertension is lifestyle modification.
Episodes of ventricular tachycardia/ventricular fibrillation (VT/VF) in patients with Brugada syndrome can be predicted by electrocardiogram (ECG) findings at the time of implantable cardioverter-defibrillator (ICD) placement including T-peak to T-end interval, according to a study presented at the 23rd ASEAN Federation of Cardiology Congress (AFCC) held in Bangkok, Thailand.
Despite being an uncommon complication of coronary artery bypass surgery (CABG), postoperative ventricular arrhythmia (POVA) increases the risk of in-hospital mortality and poor long-term prognosis, according to a recent poster presented at the recently concluded 23rd ASEAN Federation of Cardiology Congress (AFCC 2018), in Bangkok, Thailand.
Among patients who have received coronary artery bypass grafting (CABG), postoperative renal injury and failure as defined by the RIFLE criteria are only seen in the group of patients categorized as low risk of acute kidney injury (AKI) by the THAKAR score, according to a study presented at the 23rd ASEAN Federation of Cardiology Congress (AFCC 2018) in Bangkok, Thailand.
Elvira Manzano, Roshini Claire Anthony,
01 Oct 2019
The European Society of Cardiology (ESC) has released five new guidelines at the ESC Congress 2019, recommending an even lower LDL-C* target in patients at very high risk for cardiovascular disease (CVD), and the use of SGLT2** inhibitors and GLP-1*** receptor agonists as first-line treatments in those with diabetes to reduce their CVD risk.
Five years of extended therapy with the aromatase inhibitor (AI) letrozole did not improve survival in postmenopausal breast cancer patients, according to findings of the NRG Oncology/NSABP B-42 trial presented at the San Antonio Breast Cancer Symposium (SABCS 2016) held in Texas, US.
Adding everolimus to fulvestrant in second-line treatment of hormone receptor (HR)-positive, HER2-negative advanced breast cancer improves progression-free survival (PFS) by 40 percent, the phase II PrECOG 0102 study has shown. [SABCS 2016, abstract S1-02]